# Study of PAT in Patients With Solid Tumor Cancers

> **NCT05338658** · PHASE1 · RECRUITING · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 21 (estimated)

## Conditions studied

- Metastasis
- Solid Tumor

## Interventions

- **DRUG:** Peptide Alarm Therapy (PAT)

## Key facts

- **NCT ID:** NCT05338658
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-19
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 21 (ESTIMATED)
- **Last updated:** 2025-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05338658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05338658, "Study of PAT in Patients With Solid Tumor Cancers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05338658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*